Egrifta
Active Ingredient(s): Tesamorelin AcetateFDA Approved: * November 10, 2010
Pharm Company: * THERATECHNOLOGIES
Category: HIV / AIDS
Growth hormone–releasing hormone (GHRH), also known as somatocrinin or by several other names in its endogenous forms and as somatorelin (INN) in its pharmaceutical form, is a releasing hormone of growth hormone (GH). It is a 44[1]-amino acid peptide hormone produced in the arcuate nucleus of the hypothalamus. GHRH first appears in the human hypothalamus between 18 and 29 weeks of gestation, which corresponds to the start of production of growth hormone and other somatot... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.